25 XP   0   0   10

Sakar Healthcare Limited
Buy, Hold or Sell?

Let's analyse Sakar Healthcare Limited together

PenkeI guess you are interested in Sakar Healthcare Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Sakar Healthcare Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Sakar Healthcare Limited

I send you an email if I find something interesting about Sakar Healthcare Limited.

Quick analysis of Sakar Healthcare Limited (30 sec.)










What can you expect buying and holding a share of Sakar Healthcare Limited? (30 sec.)

How much money do you get?

How much money do you get?
INR0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
INR93.23
Expected worth in 1 year
INR168.31
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
INR75.08
Return On Investment
20.9%

For what price can you sell your share?

Current Price per Share
INR359.90
Expected price per share
INR316.05 - INR437.45
How sure are you?
50%

1. Valuation of Sakar Healthcare Limited (5 min.)




Live pricePrice per Share (EOD)

INR359.90

Intrinsic Value Per Share

INR-465.70 - INR-342.40

Total Value Per Share

INR-372.47 - INR-249.17

2. Growth of Sakar Healthcare Limited (5 min.)




Is Sakar Healthcare Limited growing?

Current yearPrevious yearGrowGrow %
How rich?$20.8m$15.2m$5.5m26.5%

How much money is Sakar Healthcare Limited making?

Current yearPrevious yearGrowGrow %
Making money$1.5m$1.8m-$298k-19.5%
Net Profit Margin9.6%11.9%--

How much money comes from the company's main activities?

3. Financial Health of Sakar Healthcare Limited (5 min.)




What can you expect buying and holding a share of Sakar Healthcare Limited? (5 min.)

Welcome investor! Sakar Healthcare Limited's management wants to use your money to grow the business. In return you get a share of Sakar Healthcare Limited.

What can you expect buying and holding a share of Sakar Healthcare Limited?

First you should know what it really means to hold a share of Sakar Healthcare Limited. And how you can make/lose money.

Speculation

The Price per Share of Sakar Healthcare Limited is INR359.90. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Sakar Healthcare Limited.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Sakar Healthcare Limited, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR93.23. Based on the TTM, the Book Value Change Per Share is INR18.77 per quarter. Based on the YOY, the Book Value Change Per Share is INR16.95 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Sakar Healthcare Limited.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.080.0%0.080.0%0.110.0%0.080.0%0.060.0%
Usd Book Value Change Per Share0.230.1%0.230.1%0.200.1%0.150.0%0.140.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.230.1%0.230.1%0.200.1%0.150.0%0.140.0%
Usd Price Per Share2.41-2.41-1.62-1.32-1.00-
Price to Earnings Ratio29.23-29.23-15.24-16.82-17.46-
Price-to-Total Gains Ratio10.69-10.69-7.97-8.61-7.91-
Price to Book Ratio2.15-2.15-1.82-1.63-1.61-
Price-to-Total Gains Ratio10.69-10.69-7.97-8.61-7.91-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4.3188
Number of shares231
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.230.15
Usd Total Gains Per Share0.230.15
Gains per Quarter (231 shares)52.0335.01
Gains per Year (231 shares)208.12140.04
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
102081980140130
204164060280270
306246140420410
408328220560550
50104110300700690
60124912380840830
70145714460980970
8016651654011201110
9018731862012601250
10020812070014001390

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%8.00.00.0100.0%8.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%8.00.00.0100.0%8.00.00.0100.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.08.00.0%0.00.08.00.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%8.00.00.0100.0%8.00.00.0100.0%

Fundamentals of Sakar Healthcare Limited

About Sakar Healthcare Limited

Sakar Healthcare Limited research, develops, manufactures, and markets pharmaceutical products in India. It provides liquid orals, cephalosporin tablets, capsules, dry powder syrups, dry powder injections, liquid injectable (SVP) in ampoules, vials and lyophilized injections, and oral solid dosages. The company's product portfolio consists of formulations in approximately 22 therapeutic areas, such as antacid, antimalerial, anticoagulant, laxative, anthelmintic, bronchodilator, anaesthetic, antidepressant, sedative, adrenergic, anti-infective, diuretics, oxytocic, analgesic, antiemetic, antipsychotic, antifungal, PPI, anticonvulsant, anti-inflammatory, antihistamine, and multi vitamins. It also exports its products to approximately 38 countries, including Southeast Asia, Asia, Africa-Anglo and Francophone, MENA countries, and the United States. The company was incorporated in 2004 and is based in Ahmedabad, India.

Fundamental data was last updated by Penke on 2024-04-09 11:44:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Sakar Healthcare Limited.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Sakar Healthcare Limited earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Sakar Healthcare Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 9.6% means that ₹0.10 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Sakar Healthcare Limited:

  • The MRQ is 9.6%. The company is making a profit. +1
  • The TTM is 9.6%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ9.6%TTM9.6%0.0%
TTM9.6%YOY11.9%-2.3%
TTM9.6%5Y10.9%-1.4%
5Y10.9%10Y9.4%+1.6%
1.1.2. Return on Assets

Shows how efficient Sakar Healthcare Limited is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Sakar Healthcare Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • 3.8% Return on Assets means that Sakar Healthcare Limited generated ₹0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Sakar Healthcare Limited:

  • The MRQ is 3.8%. Using its assets, the company is less efficient in making profit.
  • The TTM is 3.8%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ3.8%TTM3.8%0.0%
TTM3.8%YOY5.7%-1.9%
TTM3.8%5Y6.2%-2.4%
5Y6.2%10Y5.6%+0.6%
1.1.3. Return on Equity

Shows how efficient Sakar Healthcare Limited is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Sakar Healthcare Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • 7.4% Return on Equity means Sakar Healthcare Limited generated ₹0.07 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Sakar Healthcare Limited:

  • The MRQ is 7.4%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 7.4%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ7.4%TTM7.4%0.0%
TTM7.4%YOY12.0%-4.6%
TTM7.4%5Y10.4%-3.0%
5Y10.4%10Y10.0%+0.3%

1.2. Operating Efficiency of Sakar Healthcare Limited.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Sakar Healthcare Limited is operating .

  • Measures how much profit Sakar Healthcare Limited makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Sakar Healthcare Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 17.1% means the company generated ₹0.17  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Sakar Healthcare Limited:

  • The MRQ is 17.1%. The company is operating efficient. +1
  • The TTM is 17.1%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ17.1%TTM17.1%0.0%
TTM17.1%YOY15.0%+2.1%
TTM17.1%5Y16.5%+0.6%
5Y16.5%10Y16.1%+0.4%
1.2.2. Operating Ratio

Measures how efficient Sakar Healthcare Limited is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.86 means that the operating costs are ₹0.86 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Sakar Healthcare Limited:

  • The MRQ is 0.864. The company is less efficient in keeping operating costs low.
  • The TTM is 0.864. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.864TTM0.8640.000
TTM0.864YOY0.840+0.024
TTM0.8645Y0.848+0.016
5Y0.84810Y0.847+0.001

1.3. Liquidity of Sakar Healthcare Limited.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Sakar Healthcare Limited is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.03 means the company has ₹1.03 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Sakar Healthcare Limited:

  • The MRQ is 1.026. The company is just able to pay all its short-term debts.
  • The TTM is 1.026. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.026TTM1.0260.000
TTM1.026YOY1.070-0.044
TTM1.0265Y1.298-0.272
5Y1.29810Y1.427-0.129
1.3.2. Quick Ratio

Measures if Sakar Healthcare Limited is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Sakar Healthcare Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.53 means the company can pay off ₹0.53 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Sakar Healthcare Limited:

  • The MRQ is 0.533. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.533. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.533TTM0.5330.000
TTM0.533YOY0.918-0.386
TTM0.5335Y0.816-0.283
5Y0.81610Y0.750+0.066

1.4. Solvency of Sakar Healthcare Limited.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Sakar Healthcare Limited assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Sakar Healthcare Limited to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.48 means that Sakar Healthcare Limited assets are financed with 48.5% credit (debt) and the remaining percentage (100% - 48.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Sakar Healthcare Limited:

  • The MRQ is 0.485. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.485. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.485TTM0.4850.000
TTM0.485YOY0.524-0.039
TTM0.4855Y0.404+0.080
5Y0.40410Y0.439-0.034
1.4.2. Debt to Equity Ratio

Measures if Sakar Healthcare Limited is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Sakar Healthcare Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 94.0% means that company has ₹0.94 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Sakar Healthcare Limited:

  • The MRQ is 0.940. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.940. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.940TTM0.9400.000
TTM0.940YOY1.101-0.160
TTM0.9405Y0.728+0.212
5Y0.72810Y0.858-0.131

2. Market Valuation of Sakar Healthcare Limited

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Sakar Healthcare Limited generates.

  • Above 15 is considered overpriced but always compare Sakar Healthcare Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 29.23 means the investor is paying ₹29.23 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Sakar Healthcare Limited:

  • The EOD is 52.448. Based on the earnings, the company is expensive. -2
  • The MRQ is 29.233. Based on the earnings, the company is overpriced. -1
  • The TTM is 29.233. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD52.448MRQ29.233+23.215
MRQ29.233TTM29.2330.000
TTM29.233YOY15.240+13.993
TTM29.2335Y16.824+12.410
5Y16.82410Y17.463-0.639
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Sakar Healthcare Limited:

  • The EOD is -14.274. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -7.956. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -7.956. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-14.274MRQ-7.956-6.318
MRQ-7.956TTM-7.9560.000
TTM-7.956YOY-3.742-4.214
TTM-7.9565Y-11.928+3.972
5Y-11.92810Y-92,994.717+92,982.788
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Sakar Healthcare Limited is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 2.15 means the investor is paying ₹2.15 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Sakar Healthcare Limited:

  • The EOD is 3.860. Based on the equity, the company is fair priced.
  • The MRQ is 2.152. Based on the equity, the company is underpriced. +1
  • The TTM is 2.152. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD3.860MRQ2.152+1.709
MRQ2.152TTM2.1520.000
TTM2.152YOY1.815+0.337
TTM2.1525Y1.633+0.519
5Y1.63310Y1.611+0.022
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Sakar Healthcare Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--18.77018.7700%16.948+11%12.630+49%11.654+61%
Book Value Per Share--93.23293.2320%74.462+25%62.920+48%47.079+98%
Current Ratio--1.0261.0260%1.070-4%1.298-21%1.427-28%
Debt To Asset Ratio--0.4850.4850%0.524-8%0.404+20%0.439+10%
Debt To Equity Ratio--0.9400.9400%1.101-15%0.728+29%0.858+10%
Dividend Per Share----0%-0%-0%-0%
Eps--6.8626.8620%8.868-23%6.300+9%4.625+48%
Free Cash Flow Per Share---25.214-25.2140%-36.121+43%-15.809-37%-10.140-60%
Free Cash Flow To Equity Per Share---3.111-3.1110%-4.213+35%-0.181-94%-1.321-58%
Gross Profit Margin--0.9980.9980%0.9990%0.9990%0.989+1%
Intrinsic Value_10Y_max---342.401--------
Intrinsic Value_10Y_min---465.701--------
Intrinsic Value_1Y_max---19.842--------
Intrinsic Value_1Y_min---30.418--------
Intrinsic Value_3Y_max---70.645--------
Intrinsic Value_3Y_min---106.009--------
Intrinsic Value_5Y_max---134.742--------
Intrinsic Value_5Y_min---197.038--------
Market Cap6160768200.000+39%3729755800.0003729755800.0000%2313497700.000+61%1935994520.000+93%1459277450.000+156%
Net Profit Margin--0.0960.0960%0.119-20%0.109-12%0.094+2%
Operating Margin--0.1710.1710%0.150+14%0.165+4%0.161+6%
Operating Ratio--0.8640.8640%0.840+3%0.848+2%0.847+2%
Pb Ratio3.860+44%2.1522.1520%1.815+19%1.633+32%1.611+34%
Pe Ratio52.448+44%29.23329.2330%15.240+92%16.824+74%17.463+67%
Price Per Share359.900+44%200.600200.6000%135.150+48%109.640+83%83.088+141%
Price To Free Cash Flow Ratio-14.274-79%-7.956-7.9560%-3.742-53%-11.928+50%-92994.717+1168795%
Price To Total Gains Ratio19.174+44%10.68710.6870%7.974+34%8.608+24%7.912+35%
Quick Ratio--0.5330.5330%0.918-42%0.816-35%0.750-29%
Return On Assets--0.0380.0380%0.057-33%0.062-39%0.056-32%
Return On Equity--0.0740.0740%0.120-38%0.104-29%0.100-27%
Total Gains Per Share--18.77018.7700%16.948+11%12.630+49%11.654+61%
Usd Book Value--20801652.00020801652.0000%15295752.000+36%13254893.779+57%9876978.108+111%
Usd Book Value Change Per Share--0.2250.2250%0.203+11%0.152+49%0.140+61%
Usd Book Value Per Share--1.1191.1190%0.894+25%0.755+48%0.565+98%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.0820.0820%0.106-23%0.076+9%0.055+48%
Usd Free Cash Flow---5625732.000-5625732.0000%-7419912.000+32%-3336689.122-41%-2138605.361-62%
Usd Free Cash Flow Per Share---0.303-0.3030%-0.433+43%-0.190-37%-0.122-60%
Usd Free Cash Flow To Equity Per Share---0.037-0.0370%-0.051+35%-0.002-94%-0.016-58%
Usd Market Cap73929218.400+39%44757069.60044757069.6000%27761972.400+61%23231934.240+93%17511329.400+156%
Usd Price Per Share4.319+44%2.4072.4070%1.622+48%1.316+83%0.997+141%
Usd Profit--1531032.0001531032.0000%1829100.000-16%1327619.765+15%970925.442+58%
Usd Revenue--16003080.00016003080.0000%15387204.000+4%12181310.640+31%9690419.829+65%
Usd Total Gains Per Share--0.2250.2250%0.203+11%0.152+49%0.140+61%
 EOD+5 -3MRQTTM+0 -0YOY+21 -135Y+16 -1810Y+18 -16

3.2. Fundamental Score

Let's check the fundamental score of Sakar Healthcare Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1552.448
Price to Book Ratio (EOD)Between0-13.860
Net Profit Margin (MRQ)Greater than00.096
Operating Margin (MRQ)Greater than00.171
Quick Ratio (MRQ)Greater than10.533
Current Ratio (MRQ)Greater than11.026
Debt to Asset Ratio (MRQ)Less than10.485
Debt to Equity Ratio (MRQ)Less than10.940
Return on Equity (MRQ)Greater than0.150.074
Return on Assets (MRQ)Greater than0.050.038
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Sakar Healthcare Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.054
Ma 20Greater thanMa 50366.423
Ma 50Greater thanMa 100377.233
Ma 100Greater thanMa 200389.339
OpenGreater thanClose359.950
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets3,363,381
Total Liabilities1,629,910
Total Stockholder Equity1,733,471
 As reported
Total Liabilities 1,629,910
Total Stockholder Equity+ 1,733,471
Total Assets = 3,363,381

Assets

Total Assets3,363,381
Total Current Assets559,158
Long-term Assets2,804,223
Total Current Assets
Cash And Cash Equivalents 933
Short-term Investments 34,293
Net Receivables 220,757
Inventory 153,975
Other Current Assets 142,542
Total Current Assets  (as reported)559,158
Total Current Assets  (calculated)552,500
+/- 6,658
Long-term Assets
Property Plant Equipment 2,730,926
Other Assets 70,291
Long-term Assets  (as reported)2,804,223
Long-term Assets  (calculated)2,801,217
+/- 3,006

Liabilities & Shareholders' Equity

Total Current Liabilities544,918
Long-term Liabilities1,084,992
Total Stockholder Equity1,733,471
Total Current Liabilities
Short-term Debt 130,166
Short Long Term Debt 130,166
Accounts payable 260,881
Other Current Liabilities 56,488
Total Current Liabilities  (as reported)544,918
Total Current Liabilities  (calculated)577,701
+/- 32,783
Long-term Liabilities
Long term Debt Total 982,280
Other Liabilities 102,712
Long-term Liabilities  (as reported)1,084,992
Long-term Liabilities  (calculated)1,084,992
+/-0
Total Stockholder Equity
Common Stock190,400
Retained Earnings 688,647
Accumulated Other Comprehensive Income -6,017
Capital Surplus 860,442
Total Stockholder Equity (as reported)1,733,471
Total Stockholder Equity (calculated)1,733,472
+/- 1
Other
Capital Stock190,400
Cash And Equivalents933
Cash and Short Term Investments 35,226
Common Stock Shares Outstanding 18,593
Current Deferred Revenue97,383
Liabilities and Stockholders Equity 3,363,381
Net Debt 1,111,513
Net Invested Capital 2,845,917
Net Tangible Assets 1,733,471
Net Working Capital 14,240
Property Plant and Equipment Gross 2,730,926
Short Long Term Debt Total 1,112,446



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-31
> Total Assets 
511,095
705,874
810,997
986,849
1,151,233
1,777,924
2,677,646
3,363,381
3,363,3812,677,6461,777,9241,151,233986,849810,997705,874511,095
   > Total Current Assets 
135,774
212,261
274,193
260,821
216,523
337,231
500,244
559,158
559,158500,244337,231216,523260,821274,193212,261135,774
       Cash And Cash Equivalents 
2,293
4,518
3,623
3,668
2,959
825
298
933
9332988252,9593,6683,6234,5182,293
       Short-term Investments 
0
0
0
0
9,050
71,060
71,060
34,293
34,29371,06071,0609,0500000
       Net Receivables 
29,766
66,413
137,320
186,896
85,101
123,742
287,050
220,757
220,757287,050123,74285,101186,896137,32066,41329,766
       Inventory 
64,471
69,575
39,313
68,563
109,333
156,973
141,834
153,975
153,975141,834156,973109,33368,56339,31369,57564,471
       Other Current Assets 
69,010
138,167
231,257
1,694
19,129
179,434
2
142,542
142,5422179,43419,1291,694231,257138,16769,010
   > Long-term Assets 
375,321
493,613
536,804
726,027
934,711
1,440,692
2,177,403
2,804,223
2,804,2232,177,4031,440,692934,711726,027536,804493,613375,321
       Property Plant Equipment 
372,495
489,279
509,652
668,175
893,730
1,425,229
2,169,272
2,730,926
2,730,9262,169,2721,425,229893,730668,175509,652489,279372,495
       Long Term Investments 
0
0
971
1,522
0
0
0
0
00001,52297100
       Intangible Assets 
0
0
23,633
53,786
32,800
7,302
0
0
007,30232,80053,78623,63300
       Other Assets 
2,826
4,334
2,548
51,298
146,782
260,499
-1
70,291
70,291-1260,499146,78251,2982,5484,3342,826
> Total Liabilities 
319,272
350,844
296,071
269,812
338,037
793,402
1,403,000
1,629,910
1,629,9101,403,000793,402338,037269,812296,071350,844319,272
   > Total Current Liabilities 
121,993
127,289
127,876
140,376
142,380
332,691
467,623
544,918
544,918467,623332,691142,380140,376127,876127,289121,993
       Short-term Debt 
66,958
85,598
47,032
59,006
42,252
41,470
78,545
130,166
130,16678,54541,47042,25259,00647,03285,59866,958
       Short Long Term Debt 
27,845
85,598
47,032
59,006
42,252
41,470
45,189
130,166
130,16645,18941,47042,25259,00647,03285,59827,845
       Accounts payable 
47,875
32,213
44,073
39,895
54,406
197,798
305,042
260,881
260,881305,042197,79854,40639,89544,07332,21347,875
       Other Current Liabilities 
7,160
9,478
36,772
17,249
20,404
22,151
29,933
56,488
56,48829,93322,15120,40417,24936,7729,4787,160
   > Long-term Liabilities 
197,279
223,555
168,194
129,436
195,656
460,711
935,377
1,084,992
1,084,992935,377460,711195,656129,436168,194223,555197,279
       Long term Debt Total 
154,211
159,067
87,856
52,150
124,721
384,502
850,072
982,280
982,280850,072384,502124,72152,15087,856159,067154,211
       Other Liabilities 
43,068
64,488
69,767
65,500
70,935
76,209
85,305
102,712
102,71285,30576,20970,93565,50069,76764,48843,068
> Total Stockholder Equity
191,823
355,030
514,926
717,037
813,197
984,522
1,274,646
1,733,471
1,733,4711,274,646984,522813,197717,037514,926355,030191,823
   Common Stock
80,000
109,610
122,110
149,610
149,610
156,180
171,180
190,400
190,400171,180156,180149,610149,610122,110109,61080,000
   Retained Earnings Total Equity00000000
   Accumulated Other Comprehensive Income 
0
0
0
0
5,330
-1,555
-3,889
-6,017
-6,017-3,889-1,5555,3300000
   Capital Surplus 
0
0
0
0
0
0
546,162
860,442
860,442546,162000000
   Treasury Stock00000000
   Other Stockholders Equity 
111,823
245,420
392,816
257,404
-459,633
418,949
544,607
-879,047
-879,047544,607418,949-459,633257,404392,816245,420111,823



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2023-03-31)

Gross Profit (+$)
totalRevenue1,333,590
Cost of Revenue-735,466
Gross Profit598,124598,124
 
Operating Income (+$)
Gross Profit598,124
Operating Expense-416,562
Operating Income191,169181,562
 
Operating Expense (+$)
Research Development7,452
Selling General Administrative11,870
Selling And Marketing Expenses276
Operating Expense416,56219,598
 
Net Interest Income (+$)
Interest Income59,498
Interest Expense-59,498
Other Finance Cost-59,498
Net Interest Income-59,498
 
Pretax Income (+$)
Operating Income191,169
Net Interest Income-59,498
Other Non-Operating Income Expenses0
Income Before Tax (EBT)168,761212,426
EBIT - interestExpense = 168,710
168,761
187,084
Interest Expense59,498
Earnings Before Interest and Taxes (EBIT)228,208228,259
Earnings Before Interest and Taxes (EBITDA)378,068
 
After tax Income (+$)
Income Before Tax168,761
Tax Provision-41,175
Net Income From Continuing Ops127,586127,586
Net Income127,586
Net Income Applicable To Common Shares127,586
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses1,152,028
Total Other Income/Expenses Net-21,25759,498
 

Technical Analysis of Sakar Healthcare Limited
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Sakar Healthcare Limited. The general trend of Sakar Healthcare Limited is BEARISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Sakar Healthcare Limited's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-14.3%) Bearish trend (14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Sakar Healthcare Limited.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 385.00 < 418.00 < 437.45.

The bearish price targets are: 348.55 > 329.00 > 316.05.

Tweet this
Sakar Healthcare Limited Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Sakar Healthcare Limited. The current mas is .

The long score for the Moving Averages is 6/14.
The longshort score for the Moving Averages is -2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Sakar Healthcare Limited Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Sakar Healthcare Limited. The current macd is -4.36339906.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Sakar Healthcare Limited price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Sakar Healthcare Limited. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Sakar Healthcare Limited price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Sakar Healthcare Limited Daily Moving Average Convergence/Divergence (MACD) ChartSakar Healthcare Limited Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Sakar Healthcare Limited. The current adx is 11.63.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Sakar Healthcare Limited shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Sakar Healthcare Limited Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Sakar Healthcare Limited. The current sar is 338.31.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Sakar Healthcare Limited Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Sakar Healthcare Limited. The current rsi is 44.05. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Sakar Healthcare Limited Daily Relative Strength Index (RSI) ChartSakar Healthcare Limited Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Sakar Healthcare Limited. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Sakar Healthcare Limited price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Sakar Healthcare Limited Daily Stochastic Oscillator ChartSakar Healthcare Limited Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Sakar Healthcare Limited. The current cci is -82.02324851.

Sakar Healthcare Limited Daily Commodity Channel Index (CCI) ChartSakar Healthcare Limited Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Sakar Healthcare Limited. The current cmo is -13.67868835.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Sakar Healthcare Limited Daily Chande Momentum Oscillator (CMO) ChartSakar Healthcare Limited Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Sakar Healthcare Limited. The current willr is -68.86145405.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Sakar Healthcare Limited is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Sakar Healthcare Limited Daily Williams %R ChartSakar Healthcare Limited Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Sakar Healthcare Limited.

Sakar Healthcare Limited Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Sakar Healthcare Limited. The current atr is 15.20.

Sakar Healthcare Limited Daily Average True Range (ATR) ChartSakar Healthcare Limited Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Sakar Healthcare Limited. The current obv is 4,357,956.

Sakar Healthcare Limited Daily On-Balance Volume (OBV) ChartSakar Healthcare Limited Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Sakar Healthcare Limited. The current mfi is 30.16.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Sakar Healthcare Limited Daily Money Flow Index (MFI) ChartSakar Healthcare Limited Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Sakar Healthcare Limited.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-22MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-01BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-20BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-15MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-03CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Sakar Healthcare Limited Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Sakar Healthcare Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.054
Ma 20Greater thanMa 50366.423
Ma 50Greater thanMa 100377.233
Ma 100Greater thanMa 200389.339
OpenGreater thanClose359.950
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Sakar Healthcare Limited with someone you think should read this too:
  • Are you bullish or bearish on Sakar Healthcare Limited? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Sakar Healthcare Limited? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Sakar Healthcare Limited

I send you an email if I find something interesting about Sakar Healthcare Limited.


Comments

How you think about this?

Leave a comment

Stay informed about Sakar Healthcare Limited.

Receive notifications about Sakar Healthcare Limited in your mailbox!